Prevalence, predictors, and clinical relevance of drug–drug interactions in outpatient prescribing: A national cross-sectional study
Top Cited Papers
Open Access
- 8 April 2026
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (4) , e0345076
Abstract
Background: Drug–drug interactions (DDIs) represent a major preventable cause of medication-related harm globally. Their prevalence varies across health systems, but common drivers include polypharmacy, aging populations, and specialty-specific prescribing patterns. Large-scale pharmacoepidemiologic analyses of real-world prescription data can clarify the magnitude of the problem and inform strategies to reduce risks. Methods: This retrospective study included 2,365,811 outpatient prescriptions (982,102 patients) from Tehran, Iran. The top 100 most prescribed medications were screened for potential DDIs via Micromedex®. Interactions were classified as contraindicated, major, or moderate. Logistic regression identified demographic, specialty, and prescription-level predictors. Results: Potential DDIs occurred in 46.1% of prescriptions, with 57.8% of patients affected. Major DDIs (62.6%) dominated, followed by moderate (32.8%) and contraindicated (4.6%). ASA was a frequent contributor to high-risk pairs. Contraindicated interactions were largely NSAID duplications, most common in orthopedics and emergency medicine. Psychiatry and cardiology prescriptions showed the highest prevalence, while polypharmacy strongly predicted DDIs, with incremental risks amplified in older adults. Conclusions: Outpatient DDIs represent a substantial burden in routine care, comparable to international reports. Prevention requires comprehensive strategies, including e-prescribing with CDSS, pharmacist-led reviews, patient education on OTC use, and policy interventions to limit reimbursement of unsafe combinations.Keywords
This publication has 62 references indexed in Scilit:
- The European Drug–Drug Interaction (EuroDDI) Study Protocol: A Cross‐Country Comparison of Drug–Drug Interaction Prevalence in the Older Community‐Dwelling PopulationPharmacoepidemiology and Drug Safety, 2025
- NSAID use in orthopedic surgery: A review of current evidence and clinical practice guidelinesJournal of Orthopaedic Research, 2024
- Managing Drug–Drug Interactions in Older AdultsThe Journal of Clinical Pharmacology, 2023
- STOPP/START criteria for potentially inappropriate prescribing in older people: version 3European Geriatric Medicine, 2023
- Polypharmacy and the risk of drug–drug interactions and potentially inappropriate medications in hospital psychiatryPharmacoepidemiology and Drug Safety, 2021
- Prevalence of potential drug–drug interactions in outpatients of a general hospital in China: a retrospective investigationInternational Journal of Clinical Pharmacy, 2020
- Risk of Gastrointestinal Bleeding Increases With Combinations of Antithrombotic Agents and Patient AgeClinical Gastroenterology and Hepatology, 2020
- Drug-drug interactions and their harmful effects in hospitalised patients: a systematic review and meta-analysisEuropean Journal of Clinical Pharmacology, 2017
- Drug-drug interaction software in clinical practice: a systematic reviewEuropean Journal of Clinical Pharmacology, 2014
- Effects of Computerized Physician Order Entry and Clinical Decision Support Systems on Medication SafetyArchives of internal medicine (1960), 2003